Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.03 and last traded at C$0.04, with a volume of 89000 shares. The stock had previously closed at C$0.04.
Kane Biotech Price Performance
The company has a debt-to-equity ratio of -331.42, a quick ratio of 0.39 and a current ratio of 0.80. The company has a 50-day moving average price of C$0.04 and a 200-day moving average price of C$0.05. The firm has a market capitalization of C$4.99 million, a P/E ratio of -0.33 and a beta of 0.23.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Recommended Stories
- Five stocks we like better than Kane Biotech
- Election Stocks: How Elections Affect the Stock Market
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- What is an Earnings Surprise?
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- What is a Bond Market Holiday? How to Invest and Trade
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
